INPP5D and chronic myelogenous leukemia, BCR-ABL1 positive: Deficiency in SHIP-1 expression results in chronic myeloid leukemia in both humans and mice [24], consistent with studies reporting that SHIP-1 acts as a tumor suppressor preventing metastasis in a pre-clinical lung cancer model [25].